Tech Company Financing Transactions
Claret Medical Funding Round
On 8/22/2014, Claret Medical announced $18 million in Series B funding from Sante Ventures, Easton Capital and Lightstone Ventures.
Transaction Overview
Company Name
Announced On
8/22/2014
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds will be used primarily to complete the U.S. pivotal trial of the company's Sentinel� Cerebral Protection System (CPS) for embolic protection during transcatheter aortic valve replacement (TAVR), which received Investigational Device Exemption (IDE) approval earlier this year.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1745 Copperhill Pkwy. 1
Santa Rosa, CA 95403
USA
Santa Rosa, CA 95403
USA
Phone
Website
Email Address
Overview
Claret Medical develops cerebral vascular protection systems for Transcatheter Aortic Valve Implantation (TAVI) and other procedures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Azin Parhizgar
Chief Financial Officer
Jon Bohane
Chief Operating Officer
Tony Fields
VP - Operations
Lou Molinari
VP - R & D
Daniel Fifer
VP - Regulatory Affairs
Zachary Woodson
VP - Sales
James Hallums
Browse more venture capital transactions:
Prev: 8/22/2014: ABT Molecular Imaging venture capital transaction
Next: 8/22/2014: FeeX venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs